Multiple Sclerosis (MS): Clinical Trials

3 trials for Multiple Sclerosis (MS), newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed. 3 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 23Completed 3

Follow Multiple Sclerosis (MS): new trials by email Literature Review of Multiple Sclerosis (MS) trials Research Report on Multiple Sclerosis (MS)

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study to Assess the Safety and Efficacy of Elezanumab When Added to Standard of Care in Progressive Forms of Multiple Sclerosis
elezanumab, placebo - Multiple Sclerosis (MS)
Phase 2CompletedAbbVie1232019-02-272023-12-21
A Study to Assess the Safety and Efficacy of Elezanumab When Added to Standard of Care in Relapsing Forms of Multiple Sclerosis
elezanumab, placebo - Multiple Sclerosis (MS)
Phase 2CompletedAbbVie2082018-12-112023-12-22
Clinical Efficacy of Autologous Mesenchymal Bone Marrow Stem Cells in Active & Progressive Multiple Sclerosis
Mesenchymal stem cells - Multiple Sclerosis (MS)
Phase 2CompletedDimitrios Karussis482015-01-292019-08-01

Narrower conditions

Multiple Sclerosis (3)  ·  Multiple Sclerosis, Chronic Progressive (1)

Broader conditions

Autoimmune Diseases (3)  ·  Autoimmune Diseases of the Nervous System (3)  ·  Demyelinating Autoimmune Diseases, CNS (3)  ·  Demyelinating Diseases (3)  ·  Immune System Diseases (3)  ·  Nervous System Diseases (3)  ·  Chronic Disease (1)  ·  Disease Attributes (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)

Interventions

elezanumab (2)

Sponsors

AbbVie (2)  ·  Dimitrios Karussis (1)

Countries

Canada (2)  ·  United States (2)  ·  Israel (1)

Top investigators

Hadas Lemberg, PhD (1)

Results publications

PMID 33253391, PMID 35641166